Back to results
US 7,247,464 B2Granted
CspCI restriction endonuclease
AssigneeNew England Biolabs, Inc.
InventorsRichard Morgan, Celine Nguefeu Nkenfou
Life of this patent
Estimating the term…
Abstract
A novel restriction endonuclease has been identified from Citrobacter species 2144 (NEB#1398) which can cleave at nt sequence 5′-CAANNNNNGTGG-3′ (SEQ ID NO:13) in double-stranded DNA molecules.
Claims2
A substantially pure CspCI restriction endonuclease obtainable from Citrobacter species 2144 (ATCC Patent Accession No. PTA-5846).
Dependencies are inferred from the claim text.